Integrin and cadherin signaling in bone: Role and potential therapeutic targets

Trends in Endocrinology and Metabolism

Volumn 25, Issue 11, 2014, Pages 567-575

  Marie, Pierre J ^a   Haÿ, Eric ^a   Saidak, Zuzana ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bone formation; Bone repair; Cadherins; Integrins; Niches; Wnt signaling

Indexed keywords

BETA CATENIN; CADHERIN; CELL ADHESION MOLECULE; INTEGRIN; WNT PROTEIN;

BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL LINEAGE; EXTRACELLULAR MATRIX; HUMAN; MECHANOTRANSDUCTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOBLASTOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; ANIMAL; BONE; BONE DEVELOPMENT; METABOLISM; MOLECULARLY TARGETED THERAPY; OSTEOLYSIS; PHYSIOLOGY; PROCEDURES; THERAPY; WNT SIGNALING PATHWAY;

ANIMALS; BONE AND BONES; BONE RESORPTION; CADHERINS; CELL DIFFERENTIATION; HUMANS; INTEGRINS; MOLECULAR TARGETED THERAPY; OSTEOBLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84927694761     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.06.009     Document Type: Review

References (85)

1. Bonewald L.F. The amazing osteocyte. J. Bone Miner. Res. 2011, 26:229-238.
2. Sims N.A., Walsh N.C. Intercellular cross-talk among bone cells: new factors and pathways. Curr. Osteoporos. Rep. 2012, 10:109-117.
3. Khosla S., Riggs B.L. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol. Metab. Clin. North Am. 2005, 34:1015-1030.
4. Marie P.J. Bone cell senescence: mechanisms and perspectives. J. Bone Miner. Res. 2014, 29:1311-1321.
5. Martin T.J. Bone biology and anabolic therapies for bone: current status and future prospects. J. Bone Metab. 2014, 21:8-20.
6. Campbell I.D., Humphries M.J. Integrin structure, activation, and interactions. Cold Spring Harb. Perspect. Biol. 2011, 3:a004994.
7. Kim S.H., et al. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 2009, 209:139-151.
8. Ge C., et al. Interactions between extracellular signal-regulated kinase 1/2 and P38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J. Bone Miner. Res. 2012, 27:538-551.
9. Hannigan G.E., et al. Integrin-linked kinase: not so 'pseudo' after all. Oncogene 2011, 30:4375-4385.
10. El-Hoss J., et al. Inactivation of the integrin-linked kinase (ILK) in osteoblasts increases mineralization. Gene 2014, 533:246-252.
11. Marie P.J. Targeting integrins to promote bone formation and repair. Nat. Rev. Endocrinol. 2013, 9:288-295.
12. Globus R.K., et al. Skeletal phenotype of growing transgenic mice that express a function-perturbing form of β1 integrin in osteoblasts. Calcif. Tissue Int. 2005, 76:39-49.
13. Brunner M., et al. Osteoblast mineralization requires β1 integrin/ICAP-1-dependent fibronectin deposition. J. Cell Biol. 2011, 194:307-322.
14. Hamidouche Z., et al. Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18587-18591.
15. Hamidouche Z., et al. Crosstalks between integrin α5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol. 2010, 11:44.
16. Ono M., et al. WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J. Bone Miner. Res. 2011, 26:193-208.
17. Chen Q., et al. An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells. Stem Cells 2014, 32:327-337.
18. Su J.L., et al. CYR61 regulates BMP-2-dependent osteoblast differentiation through the αvβ3 integrin/integrin-linked kinase/ERK pathway. J. Biol. Chem. 2010, 285:31325-31336.
19. Stange R., et al. Age-related bone deterioration is diminished by disrupted collagen sensing in integrin α2β1 deficient mice. Bone 2013, 56:48-54.
20. Popov C., et al. Integrins α2β1 and α11β1 regulate the survival of mesenchymal stem cells on collagen I. Cell Death Dis. 2011, 2:e186.
21. Shih Y.R., et al. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells. J. Bone Miner. Res. 2011, 26:730-738.
22. Turner C.H., et al. Mechanobiology of the skeleton. Sci. Signal. 2009, 2:pt3.
23. Ross T.D., et al. Integrins in mechanotransduction. Curr. Opin. Cell Biol. 2013, 25:613-618.
24. Dufour C., et al. Transforming growth factor-β prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E794-E801.
25. 1 integrin and PI3K/Akt signaling pathways in mandibular osteoblasts. Exp. Cell Res. 2011, 317:2642-2649.
26. Batra N., et al. Mechanical stress-activated integrin α5β1 induces opening of connexin 43 hemichannels. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3359-3364.
27. Long R.K., et al. Skeletal unloading-induced insulin-like growth factor 1 (IGF-1) nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling. J. Bone Miner. Res. 2011, 26:2948-2958.
28. Bonnet N., et al. Regulation of β catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:15048-15053.
29. Seong J., et al. Distinct biophysical mechanisms of focal adhesion kinase mechanoactivation by different extracellular matrix proteins. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:19372-19377.
30. Robling A.G., et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 2008, 283:5866-5875.
31. Wu D., et al. Matrix-dependent adhesion mediates network responses to physiological stimulation of the osteocyte cell process. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:12096-12101.
32. Thi M.M., et al. Mechanosensory responses of osteocytes to physiological forces occur along processes and not cell body and require αVβ3 integrin. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:21012-21017.
33. Litzenberger J.B., et al. β1 integrins mediate mechanosensitive signaling pathways in osteocytes. Calcif. Tissue Int. 2010, 86:325-332.
34. Batra N., et al. Direct regulation of osteocytic connexin 43 hemichannels through AKT kinase activated by mechanical stimulation. J. Biol. Chem. 2014, 289:10582-10591.
35. Gao J., et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169:12-20.
36. Kumar S., Ponnazhagan S. Bone homing of mesenchymal stem cells by ectopic α4 integrin expression. FASEB J. 2007, 21:3917-3927.
37. Guan M., et al. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat. Med. 2012, 18:456-462.
38. Yao W., et al. Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells 2013, 31:2003-2014.
39. Fromigué O., et al. Peptide-based activation of α5 integrin for promoting osteogenesis. J. Cell. Biochem. 2012, 113:3029-3038.
40. Shekaran A., Garcia A.J. Extracellular matrix-mimetic adhesive biomaterials for bone repair. J. Biomed. Mater. Res. A 2011, 96:261-272.
41. Jabbari E. Osteogenic peptides in bone regeneration. Curr. Pharm. Des. 2013, 19:3391-3402.
42. Petrie T.A., et al. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci. Transl. Med. 2010, 2:45ra60.
43. Martino M.M., et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 2011, 3:100ra189.
44. Srouji S., et al. Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects. Hum. Gene Ther. 2012, 23:167-172.
45. Xu J.K., et al. Optimal intensity shock wave promotes the adhesion and migration of rat osteoblasts via integrin β1-mediated expression of phosphorylated focal adhesion kinase. J. Biol. Chem. 2012, 287:26200-26212.
46. Oda H., Takeichi M. Evolution: structural and functional diversity of cadherin at the adherens junction. J. Cell Biol. 2011, 193:1137-1146.
47. Nelson W.J., Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
48. Mbalaviele G., et al. Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J. Bone Miner. Res. 2006, 21:1821-1827.
49. Di Benedetto A., et al. N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms. J. Cell Sci. 2010, 123:2640-2648.
50. Castro C.H., et al. Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J. Cell Sci. 2004, 117:2853-2864.
51. Gunduz V., et al. Loss of the retinoblastoma tumor suppressor protein in murine calvaria facilitates immortalization of osteoblast-adipocyte bipotent progenitor cells characterized by low expression of N-cadherin. Mol. Cell. Biol. 2012, 32:2561-2569.
52. Haÿ E., et al. N-Cadherin/Wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging. J. Cell. Physiol. 2014, 10.1002/jcp.24629.
53. Maher M.T., et al. Activity of the β-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J. Cell Biol. 2009, 186:219-228.
54. Heuberger J., Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol. 2010, 2:a002915.
55. Haÿ E., et al. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/β-catenin signaling, osteoblast function, and bone formation. Mol. Cell. Biol. 2009, 29:953-964.
56. Haÿ E., et al. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. PLoS ONE 2009, 4:e8284.
57. Haÿ E., et al. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation. J. Bone Miner. Res. 2012, 27:1852-1863.
58. Arnsdorf E.J., et al. Non-canonical Wnt signaling and N-cadherin related β-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS ONE 2009, 4:e5388.
59. Guntur A.R., et al. N-cadherin adherens junctions mediate osteogenesis through PI3K signaling. Bone 2012, 50:54-62.
60. Wagers A.J. The stem cell niche in regenerative medicine. Cell Stem Cell 2012, 10:362-369.
61. Shiozawa Y., et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 2011, 121:1298-1312.
62. Neri P., Bahlis N.J. Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma. Curr. Cancer Drug Targets 2012, 12:776-796.
63. Matsunaga T., et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat. Med. 2003, 9:1158-1165.
64. van Roy F. Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat. Rev. Cancer 2014, 14:121-134.
65. Groen R.W., et al. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation. Haematologica 2011, 96:1653-1661.
66. Peerani R., Zandstra P.W. Enabling stem cell therapies through synthetic stem cell-niche engineering. J. Clin. Invest. 2010, 120:60-70.
67. Young S.R., et al. Focal adhesion kinase is important for fluid shear stress-induced mechanotransduction in osteoblasts. J. Bone Miner. Res. 2009, 24:411-424.
68. Leucht P., et al. FAK-mediated mechanotransduction in skeletal regeneration. PLoS ONE 2007, 2:e390.
69. Castillo A.B., et al. Focal adhesion kinase plays a role in osteoblast mechanotransduction in vitro but does not affect load-induced bone formation in vivo. PLoS ONE 2012, 7:e43291.
70. Khatiwala C.B., et al. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. J. Bone Miner. Res. 2009, 24:886-898.
71. Sen B., et al. Mechanical loading regulates NFATc1 and β-catenin signaling through a GSK3β control node. J. Biol. Chem. 2009, 284:34607-34617.
72. Ding L., Morrison S.J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013, 495:231-235.
73. Askmyr M., et al. What is the true nature of the osteoblastic hematopoietic stem cell niche?. Trends Endocrinol. Metab. 2009, 20:303-309.
74. Wu J.Y., et al. Role of the osteoblast lineage in the bone marrow hematopoietic niches. J. Bone Miner. Res. 2009, 24:759-764.
75. Arai F., et al. Role of N-cadherin in the regulation of hematopoietic stem cells in the bone marrow niche. Ann. N.Y. Acad. Sci. 2012, 1266:72-77.
76. Hosokawa K., et al. Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow. Cell Stem Cell 2010, 6:194-198.
77. Hosokawa K., et al. Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells. Blood 2010, 116:554-563.
78. Wein F., et al. N-cadherin is expressed on human hematopoietic progenitor cells and mediates interaction with human mesenchymal stromal cells. Stem Cell Res. 2010, 4:129-139.
79. Adams G.B., et al. Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 2007, 25:238-243.
80. Dominici M., et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 2009, 114:2333-2343.
81. Yao H., et al. Parathyroid hormone enhances hematopoietic expansion via upregulation of cadherin-11 in bone marrow mesenchymal stromal cells. Stem Cells 2014, 10.1002/stem.1701.
82. Lymperi S., et al. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood 2008, 111:1173-1181.
83. Kiel M.J., et al. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 2009, 4:170-179.
84. Bromberg O., et al. Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood 2012, 120:303-313.
85. Greenbaum A.M., et al. N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells. Blood 2012, 120:295-302.